XML 47 R28.htm IDEA: XBRL DOCUMENT v3.25.1

Net Loss Per Share (Tables)

12 Months Ended

Dec. 31, 2024

Earnings Per Share [Abstract]

Schedule of Anti-Dilutive Securities Outstanding Not Included in Diluted Net Loss Per Share Calculation

Anti-dilutive securities outstanding during the period not included in the diluted net loss per share calculation include the following:

		December 31,
		2024				2023
Convertible Series C Preferred Stock			5,191,375				6,135,306
Convertible Promissory Notes			149,650				—
Outstanding stock options			2,393,824				178,232
Unvested restricted stock units			213,254				214,436
Unreleased restricted stock units assumed in the Merger			17,000				—
			7,965,103				6,527,974

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration